UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046291
Receipt number R000052826
Scientific Title An exploratory study to visualization of the skin lesions with vasculitis by using photoacoustic microscope imaging equipment
Date of disclosure of the study information 2021/12/06
Last modified on 2023/06/08 10:24:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An exploratory study to visualization of the skin
lesions with vasculitis by using photoacoustic
microscope imaging equipment

Acronym

PMIE Study

Scientific Title

An exploratory study to visualization of the skin
lesions with vasculitis by using photoacoustic
microscope imaging equipment

Scientific Title:Acronym

PMIE Study

Region

Japan


Condition

Condition

Skin lesions suspicious for vasculitis

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We visualize the skin lesions which we suspect vasculitis, purpura, blood blister,ulcer,nodule and so on, by using a photoacoustic microscope imaging equipment.
We compare the visualization and the pathogenesis,then evaluate the equipment performance.

Basic objectives2

Others

Basic objectives -Others

To confirm the relationship between clinical diagnosis (photograph) and photoacoustic image.
To evaluate the performance of photoacoustic microscope imaging system.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

To visualize skin lesions of vasculitis by using a photoacoustic imaging system.
To compare the visualization with the pathogenesis.

Key secondary outcomes

To confirm the relationship between clinical diagnosis (photograph) and photoacoustic image.
To evaluate the performance of photoacoustic microscope imaging system.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients who visited our hospital with the skin lesions suspected vasculitis and need biopsy for definitive diagnosis.
2. The subjects who have agreed to participate in this study from their own free will with document consents.

Key exclusion criteria

1.Patients who are pregnant or suspected of being pregnant
2.Patients who have complications that make them impossible to try photoacoustic imaging system due to limitations in taking examination position.
3.Patients who are judged ineligible to enroll into this clinical study by the investigator or the sub-investigators.

Target sample size

4


Research contact person

Name of lead principal investigator

1st name Yoshihiro
Middle name
Last name Ito

Organization

Keio University School of Medicine

Division name

Department of Dermatology

Zip code

160-8582

Address

35 Shinanomachi Shinjuku-ku, Tokyo, JAPAN

TEL

03-5363-3823

Email

tanikawa@keio.jp


Public contact

Name of contact person

1st name Kazuyo
Middle name
Last name Sujino

Organization

Keio University School of Medicine

Division name

Department of Dermatology

Zip code

160-8582

Address

35 Shinanomachi Shinjuku-ku, Tokyo, JAPAN

TEL

03-5363-3823

Homepage URL


Email

ksujino@keio.jp


Sponsor or person

Institute

Keio University Hospital

Institute

Department

Personal name



Funding Source

Organization

Advantest Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine Ethics Committee

Address

35 Shinanomachi Shinjuku-ku, Tokyo, JAPAN

Tel

03-3353-1211

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 12 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 10 Month 10 Day

Date of IRB

2021 Year 11 Month 30 Day

Anticipated trial start date

2021 Year 12 Month 24 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2021 Year 12 Month 06 Day

Last modified on

2023 Year 06 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052826


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name